Ameriprise’s COVIDIEN PLC COM SHS NEW (IRELAND) COV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-7,684,036
Closed -$786M 4033
2014
Q4
$786M Buy
7,684,036
+543,501
+8% +$52.1M 0.46% 40
2014
Q3
$618M Sell
7,140,535
-389,880
-5% -$34.5M 0.37% 57
2014
Q2
$679M Sell
7,530,415
-650,477
-8% -$48.7M 0.4% 45
2014
Q1
$603M Buy
8,180,892
+1,041,533
+15% +$72.6M 0.36% 56
2013
Q4
$486M Buy
7,139,359
+2,637,346
+59% +$172M 0.29% 74
2013
Q3
$274M Buy
4,502,013
+1,283,510
+40% +$78.3M 0.18% 136
2013
Q2
$179M Buy
+3,218,503
New +$186M 0.12% 194

Ameriprise's COV Position: Q1 2015 in Review

Ameriprise sold out of COVIDIEN PLC COM SHS NEW (IRELAND) (COV) in Q1 2015, closing a stake of 7,684,036 shares — an estimated $786M sold.

Ameriprise first reported a position in COV in Q2 2013 and held it in 7 quarters. The position peaked at $786M in Q4 2014. 1 fund tracked by Wall St. Rank holds COV as of Q1 2015.

  • Ameriprise reported no remaining COVIDIEN PLC COM SHS NEW (IRELAND) position as of Q1 2015 after selling out during the quarter.
  • Ameriprise sold 7,684,036 COVIDIEN PLC COM SHS NEW (IRELAND) shares in Q1 2015, an estimated $786M.
  • Ameriprise first reported a position in COVIDIEN PLC COM SHS NEW (IRELAND) in Q2 2013 and held it in 7 quarters.
  • Ameriprise's COVIDIEN PLC COM SHS NEW (IRELAND) position peaked at $786M in Q4 2014.
  • 1 fund tracked by Wall St. Rank held COVIDIEN PLC COM SHS NEW (IRELAND) as of Q1 2015.

Based on Ameriprise's 13F filing for Q1 2015, filed 14 May 2015.